Furthermore, the combination treatment of MSA-2 and anti-PD-1 exhibited a remarkably suppressive effect on tumor growth when compared to either MSA-2 administration or anti-PD-1 monotherapy (Figures 6B, D). The gene discussed is PDCD1; the disease is neoplasm.